Overview

This trial is active, not recruiting.

Conditions neurodegenerative diseases, dementia
Sponsor Sykehuset Innlandet HF
Collaborator Norwegian Directorate of Health
Start date April 2009
End date January 2015
Trial size 2800 participants
Trial identifier NCT01920100, E13237

Summary

This project is based on a three-year program that aims to improve the knowledge of the socioeconomic consequences of dementia in Norway. By including patients with and without dementia in four different cohorts (from nursing homes, from memory clinics, home-dwelling persons with dementia and elderly persons without dementia), the project's aim is to describe tha course of dementia, the economical cost of dementia and to look into possible risk factors for dementia.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
People visiting a memory clinic at Ullevål University Hospital, St Olav Hospital or Innlandet Hospital Trust (n=400). The patients will be assessed three times over a three-year follow-up. Baseline inclusion started in January 2010. The final assessments will take place in spring 2014.
People admitted to a nursing home recruited from municipalities in Hedmark, Oppland, Nord-Trøndelag and Bergen (n=1000). Baseline assessments take place when the person is admitted to the nursing home. The patients will be assessed every six months over a three-year follow-up period. The first participant was included in March 2012, and baseline inclusion will be completed in December 2013.
People 70 years of age or older receiving in-home care recruited from municipalities in Hedmark, Oppland, Oslo, Østfold and Buskerud (n=995). The patients will be assessed three times over a three-year follow-up period. Baseline inclusion started in April 2009 and the final assessments will take place in December 2013.
People without dementia recruited from Nord-Trøndelag, Drammen and Oslo (n=400). The participants will be assessed three times over a three-year follow-up period. Baseline inclusion will take place in autumn 2012 and the last follow-up will take place in autumn 2015.

Primary Outcomes

Measure
Cost of dementia
time frame: 3 years

Secondary Outcomes

Measure
The course of neuropsychiatric symptoms
time frame: 3 years
Quality of Life
time frame: 3 years
Prescription of medication
time frame: 3 years
DNA polymorphism
time frame: At baseline
Organizational factors of the nursing homes
time frame: At baseline

Eligibility Criteria

Male or female participants of any age.

Memory clinic sample Inclusion Criteria: - All patients examined at a memory clinic with mild cognitive impairment or mild dementia Exclusion Criteria: In-home care sample Inclusion Criteria: - Persons 70 years of age or older receiving in-home care from the municipality Exclusion Criteria: Nursing-home sample Inclusion Criteria: - All persons admitted to the nursing home with an expected stay of more than four weeks. - Participants should be 65 years or older, unless established dementia disease, in which case younger persons also will be included Exclusion Criteria: - Life expectancy of less than six weeks Control sample Inclusion Criteria: - Persons 65 years or older without any sign of dementia Exclusion Criteria:

Additional Information

Official title Resource Use and Disease Course in Dementia (REDIC)
Principal investigator Geir Selbaek, pHd
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Sykehuset Innlandet HF.